Page 1 of Clinical Trials for "Darunavir", 114 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Recruiting
Safety and Efficacy of Darunavir/Cobicistat/Emtricitabine/GS-7340 Single Tablet Regimen Versus Cobicistat-boosted Darunavir Plus Emtricitabine/Tenofovir Disoproxil Fumarate Fixed Dose Combination in HIV-1 Infected, Antiretroviral Treatment Naive Adults
Last Updated: April 25, 2012
Condition(s): Acquired Immunodeficiency Syndrome; HIV Infections
2
Completed
Treatment Simplification by Darunavir/Ritonavir 800/100 mg Once a Day Versus a Triple Combination Therapy With Darunavir/Ritonavir
Last Updated: December 23, 2011
Condition(s): HIV Infections; AIDS Virus; Human Immunodeficiency Virus; Acquired Immunodeficiency Syndrome Virus
3
Completed
Pharmacokinetics (PK) Study of Once Daily Darunavir/Ritonavir and Twice and Once Daily Raltegravir in HIV-infected Subjects
Last Updated: January 12, 2010
Condition(s): HIV Infections
4
Recruiting
A Study to Assess the Pharmacokinetics (Blood Levels) of TMC114 (Darunavir) Taken With Ritonavir and/or TMC125 (Etravirine) and TMC278 (Rilpivirine) in HIV-1 Infected Pregnant Women
Last Updated: May 16, 2012
Condition(s): HIV; HIV Infections; Pregnancy
5
Completed
TMC114-C202: A Study of Safety, Efficacy, and Tolerability of TMC114 and Low Dose Ritonavir in HIV-1 Infected Patients
Last Updated: June 2, 2011
Condition(s): HIV Infections
6
Recruiting
TMC114-TiDP29-C232 - Study Providing Continued Access to Treatment With Darunavir (DRV)/Ritonavir (Rtv) for Children Coming From Any of the Three Ongoing Tibotec Sponsored Pediatric Studies With DRV
Last Updated: May 21, 2012
Condition(s): HIV-1 Infections
7
Recruiting
TMC114IFD3001 - Study Providing Continued Access to Treatment With Darunavir (DRV)/Ritonavir (Rtv) for Adults Coming From Any of the Three Ongoing Tibotec-Sponsored Studies With DRV
Last Updated: April 23, 2012
Condition(s): HIV-1 Infections
8
Active, not recruiting
Darunavir/Ritonavir and Rosuvastatin Pharmacokinetic Study
Last Updated: April 21, 2009
Condition(s): HIV Infections
9
Not yet recruiting
DRIVESHAFT: Darunavir/Ritonavir In HIV-infected Virologically-suppressed Experienced Subjects
Last Updated: January 10, 2012
Condition(s): HIV
10
Active, not recruiting
Study of Darunavir/r + Tenofovir/Emtricitabine vs. Darunavir/r + Raltegravir in HIV-infected Antiretroviral naïve Subjects
Last Updated: May 23, 2012
Condition(s): HIV Infections
11
Completed
Assessment of Brachial Artery Reactivity in Patients Treated With Darunavir/Ritonavir as Monotherapy and Part of a Highly Active AntiRetroviral Therapy (HAART)
Last Updated: April 27, 2012
Condition(s): HIV Infection
12
Completed
Evaluate the Efficacy and Security of Darunavir/Ritonavir 900/100 mg Once a Day as an Antiretroviral Treatment Simplification Strategy
Last Updated: October 5, 2009
Condition(s): HIV Infections
13
Recruiting
Post-prandial Lipid Effects of Raltegravir (RAL) vs Ritonavir -Boosted Darunavir (DRV-r) in Anti-retroviral Therapy (ART)- Naive Adults or Adults Recommencing ART.
Last Updated: September 30, 2011
Condition(s): HIV; Cardiovascular Disease
14
Completed
Study in Healthy Males to Measure Darunavir and Etravirine in Blood, Seminal Fluid, and Rectal Tissue
Last Updated: May 11, 2011
Condition(s): HIV/AIDS; HIV Infections
15
Recruiting
Phase 3b Open-Label, Single Arm Study to Evaluate the Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults
Last Updated: October 12, 2011
Condition(s): Acquired Immunodeficiency Syndrome; HIV Infections
16
Recruiting
A Clinical Trial Comparing the Efficacy of Darunavir/Ritonavir Monotherapy Versus a Triple Combination Therapy Containing Darunavir/Ritonavir and 2 Nucleoside/Nucleotide Reverse Transcriptase Inhibitors in Patients With Undetectable Plasma HIV-1 RNA on Current Treatment
Last Updated: May 18, 2012
Condition(s): Human Immunodeficiency Virus (HIV) Infections; Acquired Immunodeficiency Syndrome (AIDS) Virus
17
Active, not recruiting
TMC114-TiDP29-C228 - A Safety Study to Evaluate the Antiviral Activity of Darunavir (DRV) in Combination With Ritonavir (Rtv) in HIV 1 Infected Children From 3 Years to Below 6 Years of Age
Last Updated: February 10, 2011
Condition(s): HIV Infections
18
Completed
Study Comparing Efficacy and Safety of Darunavir Boosted With Ritonavir to HART With 2 NRTI and Darunavir Boosted With Ritonavir in HIV-1 Infected Patients ANRS136
Last Updated: April 8, 2011
Condition(s): HIV Infections
19
Completed
GSK1349572 Drug Interaction With Etravirine and Either Darunavir/Ritonavir or Lopinavir/Ritonavir
Last Updated: February 20, 2012
Condition(s): Healthy Volunteer
20
Active, not recruiting
Clinical Study to Evaluate the Efficacy and Safety of Lopinavir/Ritonavir Monotherapy Versus Darunavir/Ritonavir Monotherapies as Simplification Switching Strategies of PI/NNRTI-Triple Therapy Based-Regimens
Last Updated: April 2, 2012
Condition(s): HIV Infections

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?intr=%22Darunavir%22

Page 1 of Clinical Trials for "Darunavir", 114 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About